He is a medicinal chemist with 30 years’ experience in the pharmaceutical industry. Simon has been engaged in the full spectrum of drug discovery activities – from high-throughput screening, to progressing hit-to-lead campaigns and all the way to successful lead optimisation projects and candidate drug selection.
He has a broad experience of research in both a large pharmaceutical company (AstraZeneca) and a mid-size biotech (OSI Pharmaceuticals) as well as in a more commercial environment at CombiPure Ltd., where he was Managing Director and Director of Chemistry.
Simon has a BSc (Hons.) in chemistry and a PhD in synthetic organic chemistry from the University of Nottingham and undertook post-doctoral research at the University of Pittsburgh.
![](https://step-ph.com/wp-content/uploads/2022/07/SPT_Simon_Hirst.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Sunstone.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Signature.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Pontifax.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Kurma.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Inserm.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Imagine.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_idinvest.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_Hadean.jpg)
![client](https://step-ph.com/wp-content/uploads/2022/07/SP_I_bpifrance.jpg)